Hinge Health
USAWho owns Hinge Health?
Hinge Health is an American HealthTech company, currently owned by Vitruvian Partners since 2025. It changed hands in 2025, when IP Group, Atomico and Quadrille Capital sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Held by Vitruvian Partners since 2025 (1Y hold).
- ·Best return: 53.0x MOIC by IP Group (2025 exit).
- ·Average hold across 3 realized cycles: 9 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
IP Group took Hinge Health public via IPO in 2025 after 13 years.
Atomico took Hinge Health public via IPO in 2025 after 8 years.
Quadrille Capital took Hinge Health public via IPO in 2025 after 5 years.
More from Vitruvian Investment Partnership V
Other portfolio companies in the same fund.
UK
Norway
More PE-backed in HealthTech
Comparable healthtech deals from other GPs.
Questions
Who owns Hinge Health?
Hinge Health is currently owned by Vitruvian Partners, through Vitruvian Investment Partnership V, since 2025.
When did Vitruvian Partners acquire Hinge Health?
Vitruvian Partners acquired Hinge Health in 2025.
Who did Hinge Health sell to?
IP Group and Atomico sold Hinge Health to Vitruvian Partners in 2025 (IPO), 53.0x return. Quadrille Capital sold Hinge Health to Public Market in 2025 (IPO).
Who has owned Hinge Health over time?
Hinge Health has been through 4 private-equity ownership periods: IP Group · via IP Group (Evergreen) · 2012–2025 · sold to Vitruvian Partners · (IPO) · 53.0x; Atomico · via Atomico IV · 2017–2025 · sold to Vitruvian Partners · (IPO); Quadrille Capital · via Quadrille Technologies III · 2020–2025 · sold to Public Market · (IPO); Vitruvian Partners · via Vitruvian Investment Partnership V · 2025–2025.